Aging is associated with a proapoptotic endothelial progenitor cell phenotype
Erich J Kushner1, Owen J MacEneaney, Brian R Weil
1Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, CO 80309, USA.
Journal of Vascular Research
|June 1, 2011
Summary
Aging increases the susceptibility of endothelial progenitor cells (EPCs) to apoptosis. Older men show reduced antiapoptotic proteins and telomerase activity in EPCs, contributing to impaired function.
Area of Science:
- Gerontology
- Cell Biology
- Cardiovascular Research
Background:
- Endothelial progenitor cells (EPCs) are crucial for vascular repair.
- Aging is associated with impaired vascular function and increased cardiovascular risk.
- The impact of aging on EPC apoptosis sensitivity is not fully understood.
Purpose of the Study:
- To investigate whether aging enhances the sensitivity of EPCs to apoptosis.
- To compare EPC apoptosis in young versus older healthy men.
- To explore age-related changes in key apoptotic and survival proteins within EPCs.
Main Methods:
- Isolation of EPCs from young (25±1 years) and older (61±1 years) healthy men.
- Measurement of intracellular active caspase-3 concentrations following staurosporine stimulation.
- Quantification of protein expression for Akt, p70 S6-kinase, Bcl-2, 14-3-3ε, and Bax.
- Assessment of EPC telomerase activity.
Main Results:
- EPCs from older men exhibited a ~35% higher concentration of active caspase-3 compared to young men (p < 0.05).
- Protein expression of Akt, p70 S6-kinase, and Bcl-2 was significantly lower in older men's EPCs (~35%, ~75%, ~60% respectively, p < 0.05).
- EPC telomerase activity was 57% lower in older men (p < 0.05).
Conclusions:
- Aging is associated with a proapoptotic EPC phenotype.
- Reduced expression of antiapoptotic proteins and decreased telomerase activity contribute to increased EPC apoptosis in older individuals.
- These age-related changes in EPCs may underlie diminished vascular repair capacity and increased cardiovascular risk.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

